Best medical stocks under 5
All rights reserved. It has since been updated to include the most relevant information available. Investors are constantly looking for stocks that will yield massive returns. That being said, finding these stocks can seem like an overwhelming task.
Top Drug Stocks Under $5
However, amid the coronavirus chaos, buying opportunities have emerged for those bold enough to act. Here are three drug stocks that could provide a handsome payoff. Despite being one of the biggest U. The company manufactures and sells a portfolio of generic drugs, as well as maintaining a specialty division focusing on complex generics with high barriers to entry that should produce a greater return on investment.
On March 20, Amneal hopped into the coronavirus fray when it announced it would accelerate the production and distribution of hydroxychloroquine sulfate, one of the drugs identified as a possible treatment for COVID It expects to make roughly 20 million tablets by mid-April.
The company is in a repositioning phase, with its former co-CEOs having retaken the helm last August. As part of an ongoing effort to refocus on the U. Additionally, Amneal forged a strategic partnership with Fosun International to sell its products in the growing Chinese pharmaceutical market.
Amneal's stock has been beaten down. It could still be on the hook for a sizable settlement. This remains the greatest risk for the time being. The current outbreak may dampen those expectations. However, some loss may be offset by sales of the 20 million hydroxychloroquine sulfate tablets the company seeks to deliver to fight COVID While it boasts three drugs in phase 2 clinical stage trials, much of the attention it receives falls on VK, its drug for nonalcoholic steatohepatitis NASH , a condition of inflammation and damage to the liver caused by a buildup of fat there.
While it's not the most advanced drug in development, VK has demonstrated in prior clinical trials that it can lower LDL-C "bad cholesterol" , decrease liver fat, and reduce plaque-causing proteins in the arteries -- all important in treating NASH. The key trial for VK continues to enroll patients, with results expected next year. On the earnings conference call Feb.
Even if that were to double next year, Viking would have enough money to fund several years of operations. This is critical in the current market, especially because its key trial will likely take longer to get results. If the trial results are positive next year, then this stock will prove to have been an absolute buy. And it reduced sales and marketing efforts, including cutting personnel, to focus on promotional activities at high-volume clinics.
In January, Verastem licensed exclusive worldwide rights for the promising anticancer drug VS from Japanese pharma company Chugai. Verastem began human testing of VS in combination with defactinib, another one of its anticancer drugs, to treat patients with mutated forms of the KRAS protein.
Cancers with KRAS mutations have proven to be some of the most challenging to treat and include lung, colorectal, and ovarian cancers.
The investors paid a Biotechs with greater cash positions will be better positioned to weather the current global crisis. This financing, along with the company's downsizing of its sales and marketing efforts to focus on high-prescribing cancer clinics and its scaling back of clinical trials of Copiktra, should give Verastem more breathing room. Management said the cash reserves will be enough to fund operations into the fourth quarter of Biotech stocks provide investors with high-risk, high-reward scenarios.
Viking and Verastem have the potential to skyrocket upon successful clinical trials. Meanwhile, revenue-producing Amneal could be viewed as a more conservative option. Mar 26, at AM. Image source: Getty Images. Stock Advisor launched in February of Join Stock Advisor. Related Articles.
In fact, there are several pharma companies with share prices in penny stock territory (under $5) that probably shouldn't be in this ultra-high-risk. It can be hard to find good stocks under $5, even though or medical conditions; and cooperative research.
However, amid the coronavirus chaos, buying opportunities have emerged for those bold enough to act. Here are three drug stocks that could provide a handsome payoff. Despite being one of the biggest U. The company manufactures and sells a portfolio of generic drugs, as well as maintaining a specialty division focusing on complex generics with high barriers to entry that should produce a greater return on investment.
Don't Know Your Password? Interactive Tour and a Whole Lot More.
Many people want to start investing in the stock market but don't have a huge pile of capital to start with, or even a few hundred dollars to invest. However, doing your homework and using a good technical investment strategy can help you identify companies that are possibly worth your investment.
Stocks Under $5
Nevertheless, these stocks can experience huge upswings within a short time, making them ideal for careful day traders. Low float stocks have a limited number of shares available for public trading. Usually, these stocks have a float of less than 15 million shares available for public trading. InVivo Therapeutics has 4. This comprised of private placement warrants to acquire over 1. The company completed the first sale on April 17, with intentions of completing the offering within a year.
5 Strong Buy Stocks Under $5 With Massive Upside Potential
If you are looking to compare online brokers , take a look at some of our other favorites. New money is cash or securities from a non-Chase or non-J. Morgan account. Find out how. These stocks are not stock picks and are not recommendations to buy or sell a stock. Rather, these ideas should be viewed as potential opportunities for elevated levels of volatility and trader interest and thus increased liquidity. Penny-stock trading is not for beginners. The only problem is finding these stocks takes hours per day. You can today with this special offer:.
The MarketWatch News Department was not involved in the creation of this content.
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers.
